Hikma Pharmaceutical reported 42M in Ordinary Share Capital for its second fiscal semester of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Artemis Alpha ATS:LN 373K 9K
AstraZeneca AZN:LN 387M 0M
Bayer BAYN:GR € 2515M 0M
Fresenius FRE:GR € 558M 0M
Fresenius Medical Care FMS:US $ 293.03M 0.02M
Galapagos GLPG:NA € 292.59M 0.52M
Genmab GEN:DC DK 66M 0M
GlaxoSmithKline GSK:LN 1347M 0M
GRIFOLS GRF:SM € 119.6M 0M
H. Lundbeck A/S LUN:DC 996M 0
Hikma Pharmaceutical HIK:LN 42M 1000K
Lonza Group LONN:SW 74M 0
Merck MRK:GR € 565M 397M
Orion ORNBV:FH € 92.2M 0M
Recordati REC:IM € 26.14M 0M